One of such peptidomimetic, MM-102, effectively decreases the expression of HOXA9 and Meis-1, two critical MLL/WDR5 target genes in MLL fusion protein-driven leukemogenesis, and specifically induces growth inhibition and apoptosis in leukemia cells harboring MLL fusion proteins (62). This evidence concerns the gene WDR5 and leukemia.